J
J.R. Hampton
Researcher at Queen's University
Publications - 48
Citations - 2904
J.R. Hampton is an academic researcher from Queen's University. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 23, co-authored 48 publications receiving 2872 citations. Previous affiliations of J.R. Hampton include Newcastle University.
Papers
More filters
Journal ArticleDOI
TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION: Anglo-Scandinavian Study of Early Thrombolysis (ASSET)
TL;DR: Subset analysis showed that patients who had a normal electrocardiogram (ECG) at the time of randomisation had a low case fatality rate and rt-PA was associated with a 24.5% relative reduction in 1 month fatality.
Journal ArticleDOI
Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure
J.R. Hampton,D. J. Van Veldhuisen,Franz X. Kleber,Alan J. Cowley,A Ardia,P Block,A Cortina,L Cserhalmi,Ferenc Follath,G Jensen,J Kayanakis,Kong I. Lie,Giuseppe Mancia,A M Skene +13 more
TL;DR: The finding that antiarrhythmic treatment was a significant predictor of increased mortality in ibopamine-treated patients may be important, but exploratory analyses must be interpreted with caution.
Journal ArticleDOI
Mode of death in chronic heart failure A request and proposition for more accurate classification
Rajiv Narang,John G.F. Cleland,Leif Rw Erhardt,Stephen G. Ball,Andrew J.S. Coats,Alan J. Cowley,Henry J. Dargie,Alistair S. Hall,J.R. Hampton,P. A. Poole-Wilson +9 more
TL;DR: Classifying mortality in this way will help identify pathways leading to death and hence suggest therapies and strategies to reduce mortality in patients with heart failure, a group of patients whose prognosis remains poor.
Journal Article
Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison
P. A. Poole-Wilson,JohnG.F. Cleland,W Hubbard,George C. Sutton,J Pittard,C.K. Osborne,C Long,S Ingham,P Robinson,Stephen G. Ball,J.R. Hampton,N Poulter,Gordon D Murray,C Travill,RJ Bain,A Baksi,RH Baxter,A Been,K. E. Berkin,R Blackwood,RL Blandford,RM Boyle,M Buchalter,Ross T. Campbell,[No Value] Challenor,B Cheadle,Andrew J.S. Coats,Peter Collins,C Cowan,J Creamer,CM Dancy,J.M. Davies,R Davies,M Ehsanulliah,Andrew Elder,JM Fowler,RA Fulcher,MK Ghosh,R A Greenbaum,TW Greenwood,Sem Grimmer,J Harvey,A Heller,AN Henderson,T Hendra,WG Hendrey,J Hogan,K Hollinrake,P Holt,Jenny Hutton +49 more
Journal ArticleDOI
Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study
TL;DR: Treatment with alteplase made no difference to subsequent cardiac events after one month (readmissions, reinfarctions, death) nor to treatment for angina or heart failure nor to Treatment forAngina and heart failure irrespective of other recognised cardiac risk factors.